Annual Accounts Payable
$1.94 M
+$144.00 K+8.01%
31 December 2022
Summary:
Zynerba Pharmaceuticals annual accounts payable is currently $1.94 million, with the most recent change of +$144.00 thousand (+8.01%) on 31 December 2022. During the last 3 years, it has fallen by -$579.90 thousand (-22.99%).ZYNE Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$2.48 M
+$337.10 K+15.74%
30 June 2023
Summary:
Zynerba Pharmaceuticals quarterly accounts payable is currently $2.48 million, with the most recent change of +$337.10 thousand (+15.74%) on 30 June 2023.ZYNE Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZYNE Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -23.0% | -6.0% |
| 5 y5 years | -56.5% | -24.9% |
ZYNE Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -59.0% | -61.1% |
Zynerba Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $2.48 M(+15.7%) |
| Mar 2023 | - | $2.14 M(+10.3%) |
| Dec 2022 | $1.94 M(+8.0%) | $1.94 M(+19.9%) |
| Sept 2022 | - | $1.62 M(-3.3%) |
| June 2022 | - | $1.67 M(+4.4%) |
| Mar 2022 | - | $1.60 M(-10.8%) |
| Dec 2021 | $1.80 M(-28.7%) | $1.80 M(-31.8%) |
| Sept 2021 | - | $2.64 M(+44.9%) |
| June 2021 | - | $1.82 M(+8.4%) |
| Mar 2021 | - | $1.68 M(-33.5%) |
| Dec 2020 | $2.52 M(-46.8%) | $2.52 M(-25.9%) |
| Sept 2020 | - | $3.40 M(-12.3%) |
| June 2020 | - | $3.88 M(+16.7%) |
| Mar 2020 | - | $3.33 M(-29.8%) |
| Dec 2019 | $4.74 M(+6.3%) | $4.74 M(+43.6%) |
| Sept 2019 | - | $3.30 M(-11.7%) |
| June 2019 | - | $3.74 M(-5.2%) |
| Mar 2019 | - | $3.95 M(-11.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $4.46 M(+33.0%) | $4.46 M(+25.6%) |
| Sept 2018 | - | $3.55 M(-44.3%) |
| June 2018 | - | $6.38 M(+38.5%) |
| Mar 2018 | - | $4.61 M(+37.3%) |
| Dec 2017 | $3.36 M(+81.6%) | $3.36 M(+7.7%) |
| Sept 2017 | - | $3.12 M(+53.9%) |
| June 2017 | - | $2.02 M(+103.1%) |
| Mar 2017 | - | $996.90 K(-46.1%) |
| Dec 2016 | $1.85 M(+124.4%) | $1.85 M(+9.1%) |
| Sept 2016 | - | $1.69 M(-36.8%) |
| June 2016 | - | $2.68 M(+171.0%) |
| Mar 2016 | - | $989.40 K(+20.2%) |
| Dec 2015 | $823.40 K(+162.3%) | $823.40 K(+33.8%) |
| Sept 2015 | - | $615.50 K(-65.3%) |
| June 2015 | - | $1.78 M(+16.9%) |
| Mar 2015 | - | $1.52 M(+383.8%) |
| Dec 2014 | $313.90 K(+1.8%) | $313.90 K |
| Dec 2013 | $308.30 K | - |
FAQ
- What is Zynerba Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Zynerba Pharmaceuticals?
- What is Zynerba Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Zynerba Pharmaceuticals?
What is Zynerba Pharmaceuticals annual accounts payable?
The current annual accounts payable of ZYNE is $1.94 M
What is the all time high annual accounts payable for Zynerba Pharmaceuticals?
Zynerba Pharmaceuticals all-time high annual accounts payable is $4.74 M
What is Zynerba Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of ZYNE is $2.48 M
What is the all time high quarterly accounts payable for Zynerba Pharmaceuticals?
Zynerba Pharmaceuticals all-time high quarterly accounts payable is $6.38 M